Skip to main content
ARTELO BIOSCIENCES, INC. logo

ARTELO BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · ARTL ISIN · US04301G7060 US Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2017-10-03 Regulatory Filings
Country US United States of America
Listing US ARTL

About ARTELO BIOSCIENCES, INC.

https://artelobio.com/

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics. The company's scientific approach is centered on modifying lipid-signaling pathways, particularly by modulating the endocannabinoid system. Its primary therapeutic focus is on developing improved treatments for patients with cancer and other serious diseases. Artelo is advancing a diverse portfolio of drug candidates through its development pipeline to address unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 8-K/A1
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A, which is an amendment to a previously filed Form 8-K. It is a current report filed pursuant to the Securities Exchange Act of 1934. The text indicates that this amendment is solely to refile an exhibit (Exhibit 4.2 - Form of Series A Warrant) due to an incorrect version in the original filing. There is no substantive financial data, management discussion, or detailed report content. The document is short (2243 characters) and primarily serves as a regulatory filing to correct a previous submission. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2017-10-03 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated September 20, 2017. The key content is the announcement of the increase in the size of the board of directors and the appointment of two new directors, including their biographies and related compensatory arrangements. There is no financial data or report content, but rather a disclosure of changes in the company's board of directors. This fits the category of Board/Management Information (MANG). The document length is 6895 characters, which is sufficient for a detailed announcement but does not contain financial statements or earnings data. Therefore, the classification is MANG with high confidence.
2017-09-25 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content includes details about entering into material definitive agreements (subscription agreements, license agreements), unregistered sales of equity securities, appointment of a new director to the board, and other corporate governance matters. It is not a full annual or quarterly report, nor is it a transcript or earnings release. The document is lengthy (15,000 characters) and contains detailed descriptions of agreements and management changes, typical of an 8-K filing. Therefore, the filing type corresponds to a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2017-08-04 English
FORM 10-Q
Interim / Quarterly Report 9M 2017
2017-07-21 English
NT 10-Q
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the registrant, Artelo Biosciences, Inc., is unable to file its Quarterly Report on Form 10-Q for the period ended May 31, 2017 within the prescribed time period and requests additional time. The document does not contain the actual financial statements or substantive financial data of the 10-Q report but is merely a notification of delay. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document related to filing deadlines and does not contain the report itself.
2017-07-18 English
Regulatory Filings 2017
Regulatory Filings
2017-07-17 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.